CGEM
Price
$8.19
Change
+$0.52 (+6.78%)
Updated
Aug 22 closing price
Capitalization
483.82M
74 days until earnings call
MDNAF
Price
$0.79
Change
-$0.01 (-1.25%)
Updated
Aug 22 closing price
Capitalization
66.13M
83 days until earnings call
Interact to see
Advertisement

CGEM vs MDNAF

Header iconCGEM vs MDNAF Comparison
Open Charts CGEM vs MDNAFBanner chart's image
Cullinan Therapeutics
Price$8.19
Change+$0.52 (+6.78%)
Volume$629.42K
Capitalization483.82M
Medicenna Therapeutics
Price$0.79
Change-$0.01 (-1.25%)
Volume$29.62K
Capitalization66.13M
CGEM vs MDNAF Comparison Chart in %
Loading...
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGEM vs. MDNAF commentary
Aug 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGEM is a Buy and MDNAF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 24, 2025
Stock price -- (CGEM: $8.19 vs. MDNAF: $0.79)
Brand notoriety: CGEM and MDNAF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGEM: 181% vs. MDNAF: 71%
Market capitalization -- CGEM: $483.82M vs. MDNAF: $66.13M
CGEM [@Biotechnology] is valued at $483.82M. MDNAF’s [@Biotechnology] market capitalization is $66.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.31B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGEM’s FA Score shows that 1 FA rating(s) are green whileMDNAF’s FA Score has 0 green FA rating(s).

  • CGEM’s FA Score: 1 green, 4 red.
  • MDNAF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CGEM and MDNAF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGEM’s TA Score shows that 7 TA indicator(s) are bullish while MDNAF’s TA Score has 5 bullish TA indicator(s).

  • CGEM’s TA Score: 7 bullish, 1 bearish.
  • MDNAF’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CGEM is a better buy in the short-term than MDNAF.

Price Growth

CGEM (@Biotechnology) experienced а +6.92% price change this week, while MDNAF (@Biotechnology) price change was +3.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.57%. For the same industry, the average monthly price growth was +18.06%, and the average quarterly price growth was +26.94%.

Reported Earning Dates

CGEM is expected to report earnings on Nov 06, 2025.

MDNAF is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+2.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGEM($484M) has a higher market cap than MDNAF($66.1M). MDNAF YTD gains are higher at: -30.873 vs. CGEM (-32.759). MDNAF has higher annual earnings (EBITDA): -21.81M vs. CGEM (-234.39M). CGEM has more cash in the bank: 265M vs. MDNAF (20.5M). MDNAF has less debt than CGEM: MDNAF (162K) vs CGEM (1.52M). CGEM (0) and MDNAF (0) have equivalent revenues.
CGEMMDNAFCGEM / MDNAF
Capitalization484M66.1M732%
EBITDA-234.39M-21.81M1,075%
Gain YTD-32.759-30.873106%
P/E RatioN/AN/A-
Revenue00-
Total Cash265M20.5M1,293%
Total Debt1.52M162K938%
FUNDAMENTALS RATINGS
MDNAF: Fundamental Ratings
MDNAF
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGEMMDNAF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 6 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CGEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDNAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYWCX41.681.29
+3.19%
Rydex S&P SmallCap 600 Pure Growth C
OLVTX21.040.42
+2.04%
JPMorgan Large Cap Value R3
PGTRX74.291.28
+1.75%
Putnam Global Technology R
MKGCX30.280.45
+1.51%
BlackRock Advantage Global K
GIDUX8.250.11
+1.35%
Goldman Sachs Intl Eq Div & Prem R6

MDNAF and

Correlation & Price change

A.I.dvisor tells us that MDNAF and LRMR have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDNAF and LRMR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDNAF
1D Price
Change %
MDNAF100%
-1.06%
LRMR - MDNAF
25%
Poorly correlated
+5.96%
VIR - MDNAF
25%
Poorly correlated
+4.57%
STOK - MDNAF
23%
Poorly correlated
-0.61%
CGEM - MDNAF
23%
Poorly correlated
+6.78%
PTCT - MDNAF
22%
Poorly correlated
+3.37%
More